Vancomycin-resistant enterococci from humans and retail chickens in Taiwan with unique VanB phenotype-vanA genotype incongruence

Antimicrobial Agents and Chemotherapy

Volumn 46, Issue 2, 2002, Pages 525-527

  Lauderdale, Tsai Ling ^a   McDonald, L Clifford ^a   Shiau, Yih Ru ^a   Chen, Pei Chen ^a   Wang, Hui Yin ^a   Lai, Jui Fen ^a   Ho, Monto ^a  

^a NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AZTREONAM; GLYCOPEPTIDE; TEICOPLANIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENETICS; BACTERIUM ISOLATION; CHICKEN; CONTROLLED STUDY; ENTEROCOCCUS; GENE MUTATION; GENE SEQUENCE; GENOTYPE; HUMAN; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SEQUENCE ANALYSIS; TAIWAN;

ANIMALS; BACTERIAL PROTEINS; CHICKENS; ENTEROCOCCUS; GENOTYPE; HUMANS; MUTATION; PROTEIN KINASES; TAIWAN; TRANSCRIPTION FACTORS; TRANSDUCTION, GENETIC; VANCOMYCIN RESISTANCE;

EID: 0036146234     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.46.2.525-527.2002     Document Type: Article

References (28)

1. Occurrence of glycopeptide resistance among Enterococcus faecium isolates from ecological and conventional poultry farms
2. Characterization of Tn3-related transposon conferring glycopeptide resistance by synthesis of depsipeptide peptidoglycan precursors in Enterococcus faecium BM4147
3. The vanZ gene of Tn1546 from Enterococcus faecium BM4147 confers resistance to teicoplanin
4. Avoparcin used as a growth promoter is associated with the occurrence of vancomycin-resistant Enterococcus faecium on Danish poultry and pig farms
5. Glycopeptide resistance in Enterococcus faecium from broilers following discontinued use of avoparcin
6. Farm animals as a putative reservoir for vancomycin-resistant enterococcal infection in man
7. Clinical isolation of vancomycin-resistant Enterococcus faecalis in Taiwan
8. Vancomycin-resistant enterococci
9. Vancomycin-resistant enterococci in North-Eastern Taiwan
10. Vancomycin-resistant enterococci from nosocomial, community and animal sources in the United States
11. Comparison of glycopeptide-resistant Enterococcus faecium isolates and glycopeptide resistance genes of human and animal origins
12. Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR
13. Enterococcus
14. Identification of chromosomal mobile element conferring high-level vancomycin resistance in Enterococcus faecium
15. Amino acid substitutions in the VanS sensor of the VanA-type vancomycin-resistant Enterococcus strains result in high-level vancomycin resistance and low-level teicoplanin resistance
16. Surveillance of antibiotic resistance in Taiwan, 1998
17. Antimicrobial susceptibilities of clinical isolates of vancomycin-resistant enterococci in Taiwan
18. Molecular analysis of Tn1546 in Enterococcus faecium isolated from animal and humans
19. Decreased incidence of VanA-type vancomycin resistant enterococci isolated from poultry meat and from fecal samples of humans in the community after discontinuation of avoparcin usage in animal husbandry
20. Vancomycin-resistant enterococci outside the health-care setting: Prevalence, sources, and public health implications
21. Vancomycin-resistant enterococci
22. Diversity among multidrug-resistant enterococci
23. Characterization of Tn1547, a composite transposon flanked by the IS16 and IS256-like elements, that confers vancomycin resistance in Enterococcus faecalis BM4281
24. Vancomycin-resistant enterococci in turkeys and farmers
25. Molecular characterization of vancomycin-resistant enterococci from hospitalized patients and poultry products in The Netherlands
26. Use of antimicrobial growth promoters in food animals and Enterococcus faecium resistance to therapeutic antimicrobial drugs in Europe